Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Steven A. Narod, Marie Pierre Dubé, Jan Klijn, Jan Lubinski, Henry T. Lynch, Parviz Ghadirian, Daine Provencher, Ketil Heimdal, Pal Moller, Mark Robson, Kenneth Offit, Claudine Isaacs, Barbara Weber, Eitan Friedman, Ruth Gershoni-Baruch, Gad Rennert, Barbara Pasini, Theresa Wagner, Mary Daly, Judy E. GarberSusan L. Neuhausen, Peter Ainsworth, Hakan Olsson, Gareth Evans, Michael Osborne, Fergus Couch, William D. Foulkes, Ellen Warner, Charmaine Kim-Sing, Olufunmilayo Olopade, Nadine Tung, Howard M. Saal, Jeffrey Weitzel, Sofia Merajver, Marion Gauthier-Villars, Helena Jernstrom, Ping Sun, Jean Sebastien Brunet

Research output: Contribution to journalArticlepeer-review

296 Scopus citations

Fingerprint

Dive into the research topics of 'Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers'. Together they form a unique fingerprint.

Medicine & Life Sciences